Open AccessNon-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies
Author(s) -
Francesco Cortiula,
Giacomo Pelizzari,
Carla Corvaja,
Giovanna De Maglio,
Gianpiero Fasola
Publication year - 2022
Publication title -
anti-cancer drugs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.651
H-Index - 93
eISSN - 1473-5741
pISSN - 0959-4973
DOI - 10.1097/cad.0000000000001321
Subject(s) - afatinib , osimertinib , gefitinib , epidermal growth factor receptor , lung cancer , exon , mutation , cancer research , medicine , tyrosine kinase , oncology , erlotinib , cancer , biology , receptor , genetics , gene